Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
2 reports, 1 independent
Updated Jul 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Citigroup
American investment bank and financial services corporation
Related events
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.
- Kiora Pharmaceuticals and Spero Therapeutics Inc. are listed on Nasdaq, with MarketBeat providing analyst ratings for Spero.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Benzinga reported on Cirrus Logic stock, which is listed on Nasdaq, following a price target cut by Susquehanna.